Physician profile
Anne Lenz
NPI 1093908048
$5,250.25
in general payments reported to CMS, 2019-2025
33 companies · $1,392 in 2025
The $1,392 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.90 · 2020: $86.06 · 2021: $577 · 2022: $750 · 2023: $1,141 · 2024: $1,273 · 2025: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,805.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $558.01 | 2020-2025 | |
| Ascendis Pharma Endocrinology INC | $547.59 | 2022-2025 | Skytrofa |
| Dexcom, INC. | $432.69 | 2019-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $372.70 | 2023-2025 | |
| Novo Nordisk INC | $358.06 | 2023-2025 | Sogroya, Wegovy |
| Neurocrine Biosciences, INC. | $297.06 | 2024-2025 | Ingrezza |
| Eton Pharmaceuticals, INC. | $287.44 | 2023-2025 | Alkindi, Increlex, Khindivi |
| Pfizer INC. | $232.92 | 2019-2025 | |
| Insulet Corporation | $225.89 | 2021-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $216.56 | 2021-2025 | Gvoke Hypopen |
| Azurity Pharmaceuticals, INC. | $195.23 | 2023-2025 | Triptodur, Triptodur |
| Abbott Laboratories | $189.04 | 2021-2025 | Freestyle Libre 2 |
| Tolmar Pharmaceuticals, INC. | $152.25 | 2021-2022 | |
| Beta Bionics, INC. | $140.30 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Lifescan, INC. | $133.11 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $126.05 | 2021-2023 | Minimed 780g |
| Tolmar, INC. | $102.86 | 2023-2025 | Fensolvi |
| Takeda Pharmaceuticals U.S.A., INC. | $93.15 | 2023-2024 | Vpriv |
| Endo USA, INC. | $83.59 | 2024-2025 | Supprelin |
| Tandem Diabetes Care, INC. | $81.03 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $61.50 | 2023-2025 | Crysvita |
| Genzyme Corporation | $50.00 | 2023-2024 | |
| Zealand Pharma US, INC. | $42.57 | 2022 | |
| Sequel Med Tech, LLC | $41.74 | 2025 | Twiist |
| Rhythm Pharmaceuticals, INC. | $37.42 | 2022-2023 | Imcivree |
| Endo Pharmaceuticals INC. | $35.94 | 2021-2022 | |
| Biomarin Pharmaceutical INC. | $26.59 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $24.67 | 2023 | Crysvita |
| Ibsa Pharma INC. | $24.33 | 2024 | Tirosint, Licart |
| Chiesi USA, INC. | $23.45 | 2024 | Myalept |
| Lilly USA, LLC | $19.63 | 2022 | |
| Recordati_rare_diseases_inc. | $18.44 | 2022 | |
| Eusa Pharma (US) LLC | $18.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Lenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.